Content deleted Content added
|
|
|
'''میٹوپروول''' یس '''لوپریسر''' برانڈ ناوس تحت کٕنٛنہٕ چھ یوان، چھ اَکھ دوا یس انجنا تہٕ متعدد حالاتن ہنٛد علاج کرنہٕ خٲطرٕ اِستِمال چھ یوان کرنہٕ یَتھ مَنٛز غیر معمولی طور پٲٹھؠ تیز دلٕچ شرح شٲمل چھ۔<ref name="AHFS2014">{{ویب حَوالہٕ|title=Metoprolol|url=https://www.drugs.com/monograph/metoprolol-succinate.html|url-status=live|archive-url=https://web.archive.org/web/20140312062359/http://www.drugs.com/monograph/metoprolol-succinate.html|archive-date=12 March 2014|access-date=21 April 2014|publisher=The American Society of Health-System Pharmacists}}</ref> یہِ چھ مایوکارڈیل انفکشن پتہٕ دلٕک مزید مسلہٕ رکاونہٕ خٲطرٕ تہٕ ماگرین وٲلؠ افرادن مَنٛز سردرد رکاونہٕ خٲطرٕہ اِستِمال کرنہٕ یوان۔<ref name="AHFS2014" /> یہِ چھ اَکھ منتخب β<sub>1</sub> ریسیپٹر بلاکر دوا۔<ref name="AHFS2014" /> یہِ چھ واتہٕ سٟتؠ ننہٕ یوان یا چھ نس کہ ذریعہٕ یوان دنہٕ۔<ref name="AHFS2014" />
عام ضمنی اثراتس مَنٛز چھُ سونٛچنس مَنٛز دشوٲری، تھکاوٹ، بے ہوش گژھن تہٕ یڈ ہُنٛد تکلیف شٲمل۔<ref name="AHFS2014" /> بٔڑؠ ڈوز چھِ شدید زہریلی ہنٛد سبب بنان۔<ref>{{کِتاب حَوالہٕ|title=Modern Medical Toxicology|vauthors=Pillay VV|date=2012|publisher=Jaypee Brothers Publishers|isbn=978-9350259658|page=303|chapter=Diuretics, Antihypertensives, and Antiarrhythmics|chapter-url=https://books.google.com/books?id=MFcHBAAAQBAJ&pg=PA303|archive-url=https://web.archive.org/web/20170707102252/https://books.google.ca/books?id=MFcHBAAAQBAJ&pg=PA303|archive-date=7 July 2017|url-status=live}}</ref><ref name="Rosen2014">{{کِتاب حَوالہٕ|title=Rosen's emergency medicine : concepts and clinical practice|vauthors=Marx JA|date=2014|publisher=Elsevier/Saunders|isbn=978-1455706051|edition=8th|location=Philadelphia, PA|chapter=Chapter 152: Cardiovascular Drugs}}</ref> حملس مَنٛز چھ نہٕ خطرے سٕتؠسٟتؠ انکار کرنہٕ آمتؠ کینٛہہ۔ <ref name="AHFS2014">{{ویب حَوالہٕ|title=Metoprolol|url=https://www.drugs.com/monograph/metoprolol-succinate.html|url-status=live|archive-url=https://web.archive.org/web/20140312062359/http://www.drugs.com/monograph/metoprolol-succinate.html|archive-date=12 March 2014|access-date=21 April 2014|publisher=The American Society of Health-System Pharmacists}}<cite class="citation web cs1" data-ve-ignore="true">[https://www.drugs.com/monograph/metoprolol-succinate.html "Metoprolol"]. </cite></ref><ref name="Australian Government">{{ویب حَوالہٕ|date=3 March 2014|title=Prescribing medicines in pregnancy database|url=http://www.tga.gov.au/hp/medicines-pregnancy.htm|url-status=live|archive-url=https://web.archive.org/web/20140408040902/http://www.tga.gov.au/hp/medicines-pregnancy.htm|archive-date=8 April 2014|access-date=22 April 2014|website=Australian Government}}<cite class="citation web cs1" data-ve-ignore="true">[http://www.tga.gov.au/hp/medicines-pregnancy.htm "Prescribing medicines in pregnancy database"]. </cite></ref> یہٕ چھ دۄد چاوناونس مَنٛز مۄحفوٗظ نظر یوان۔<ref name="Medical Toxicology">{{کِتاب حَوالہٕ|url=https://books.google.com/books?id=BfdighlyGiwC&pg=PA684|title=Medical Toxicology|date=2004|publisher=Lippincott Williams & Wilkins|isbn=978-0781728454|page=684|archive-url=https://web.archive.org/web/20170707085635/https://books.google.ca/books?id=BfdighlyGiwC&pg=PA684|archive-date=7 July 2017|url-status=live}}</ref> میٹروپرولک میٹابولزم چھ مریضن مَنٛز بٔڑس پیمانس پؠٹھ مختلف آسان، اکثر ہیپاٹک خرابی یا CYP2D6 پولیمرفزم کہ نتیجس مَنٛز۔<ref name="pmid7333059">{{Cite journal|vauthors=Regårdh CG, Jordö L, Ervik M, Lundborg P, Olsson R, Rönn O|date=1981|title=Pharmacokinetics of metoprolol in patients with hepatic cirrhosis|journal=Clinical Pharmacokinetics|volume=6|issue=5|pages=375–388|doi=10.2165/00003088-198106050-00004|pmid=7333059}}<cite class="citation journal cs1" data-ve-ignore="true" id="CITEREFRegårdhJordöErvikLundborg1981">Regårdh CG, Jordö L, Ervik M, Lundborg P, Olsson R, Rönn O (1981). </cite></ref><ref name="pmid23665868">{{Cite journal|vauthors=Blake CM, Kharasch ED, Schwab M, Nagele P|date=September 2013|title=A meta-analysis of CYP2D6 metabolizer phenotype and metoprolol pharmacokinetics|journal=Clinical Pharmacology and Therapeutics|volume=94|issue=3|pages=394–9|doi=10.1038/clpt.2013.96|pmc=3818912|pmid=23665868}}<cite class="citation journal cs1" data-ve-ignore="true" id="CITEREFBlakeKharaschSchwabNagele2013">Blake CM, Kharasch ED, Schwab M, Nagele P (September 2013). </cite></ref>
|
